(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-18 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 1030580
| Date | Daily Closing Price | Open | High | Low | Volume |
| 18 Mon Nov 2024 | 3.52 | 3.64 | 3.68 | 3.49 | 1.032 times |
| 15 Fri Nov 2024 | 3.64 | 3.68 | 3.68 | 3.42 | 1.738 times |
| 14 Thu Nov 2024 | 3.63 | 3.66 | 3.81 | 3.63 | 1.107 times |
| 13 Wed Nov 2024 | 3.65 | 3.65 | 3.76 | 3.65 | 0.633 times |
| 12 Tue Nov 2024 | 3.64 | 3.73 | 3.75 | 3.61 | 0.756 times |
| 11 Mon Nov 2024 | 3.73 | 3.75 | 3.84 | 3.73 | 0.805 times |
| 08 Fri Nov 2024 | 3.75 | 3.75 | 3.79 | 3.70 | 0.888 times |
| 07 Thu Nov 2024 | 3.73 | 3.92 | 3.92 | 3.70 | 1.023 times |
| 06 Wed Nov 2024 | 3.92 | 3.85 | 3.96 | 3.60 | 1.5 times |
| 05 Tue Nov 2024 | 3.96 | 3.86 | 3.96 | 3.80 | 0.633 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 3.5, for a target of 3.7 or 3.85
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 3.05 |
| Downside Target | 3.30 |
| Downside Target | 3.42 |
| Downside Target | 3.49 |
| Upside Target | 3.60 |
| Upside Target | 3.79 |
| Upside Target | 3.96 |
| Upside Target | 3.98 |
| Upside Target | 3.99 |
| Upside Target | 4.10 |
| Upside Target | 4.15 |
| Upside Target | 4.35 |
| Upside Target | 4.73 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.45 |
| Downside Intraday Target | 3.37 |
| Upside Intraday Target | 3.64 |
| Upside Intraday Target | 3.75 |
| Upside Intraday Target | 3.56 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 18 Mon Nov 2024 | 3.52 | 3.64 | 3.68 | 3.49 | 0.205 times |
| 15 Fri Nov 2024 | 3.64 | 3.75 | 3.84 | 3.42 | 1.016 times |
| 08 Fri Nov 2024 | 3.75 | 3.96 | 3.96 | 3.60 | 1.861 times |
| 01 Fri Nov 2024 | 3.96 | 4.01 | 4.10 | 3.80 | 0.774 times |
| 25 Fri Oct 2024 | 3.97 | 4.15 | 4.15 | 3.91 | 0.528 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 18 Mon Nov 2024 | 3.52 | 3.85 | 3.99 | 3.42 | 0.635 times |
| 31 Thu Oct 2024 | 3.85 | 3.81 | 4.35 | 3.65 | 0.552 times |
| 30 Mon Sep 2024 | 3.85 | 3.89 | 4.73 | 3.79 | 1.599 times |
| 30 Fri Aug 2024 | 3.87 | 3.64 | 3.95 | 3.30 | 1.02 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.71 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.71 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.